Community-acquired respiratory infections: spectrum of organisms and treatment.
The respiratory infections addressed in this paper include otitis media, sinusitis, and community-acquired pneumonia. The morbidity and mortality of respiratory infections are assessed from the American standpoint ; their worldwide significance is even greater. The emphasis is on specific diagnosis. Treatment options vary from country to country. Therapeutic decisions are usually easy once a specific etiologic organism is isolated. Since in many of these common respiratory infections a specific microorganism is not documented and empiric therapy is designed based on past clinical studies, resistance patterns need to be known for each country.
McKellar
P P
PP
Department of Internal Medicine, University of Arizona Medical School, Phoenix 85006, USA. peter@samaritan.edu
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology*; D001428:Bacterial Vaccines; D017714:Community-Acquired Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology*; D004352:Drug Resistance, Microbial; D019348:Empiricism; D006801:Humans; D008826:Microbial Sensitivity Tests; D009017:Morbidity; D010033:Otitis Media / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology*; D018579:Patient Selection; D018410:Pneumonia, Bacterial / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology*; D011159:Population Surveillance; D012852:Sinusitis / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology*; D014481:United States / Q000453:epidemiology
D000900:Anti-Bacterial Agents; D001428:Bacterial Vaccines